It is given through the nose, not as an injection
Hong Kong researchers have developed a vaccine, the first of its kind. It can protect against the emerging corona virus and influenza together, according to what Al-Hurra reported today, Saturday.
Yuen Kwok Young, head of the infectious diseases department in the Department of Microbiology at the University of Hong Kong, indicated that experiments showed that the vaccine works well in animals.
The vaccine uses a weakened influenza virus that only grows in the upper airway and cannot reproduce, and it has been genetically engineered to include the Corona virus protein as well.
The vaccine will trigger an immune response and the production of antibodies that will prevent the real virus from spreading in the body. It will also stimulate the immune system to respond to the influenza virus that was used in the vaccine, but other types of influenza viruses may still be contagious.
The prospective vaccine is scheduled to enter the first phase trials in Hong Kong next November, and it will be given to volunteers through the nose, and not through the body injection, as is the case with most vaccines.
Sabaq electronic newspaper
Previously
2020-10-10
Hong Kong researchers have developed a vaccine, the first of its kind. It can protect against the emerging corona virus and influenza together, according to what Al-Hurra reported today, Saturday.
Yuen Kwok Young, head of the infectious diseases department in the Department of Microbiology at the University of Hong Kong, indicated that experiments showed that the vaccine works well in animals.
The vaccine uses a weakened influenza virus that only grows in the upper airway and cannot reproduce, and it has been genetically engineered to include the Corona virus protein as well.
The vaccine will trigger an immune response and the production of antibodies that will prevent the real virus from spreading in the body. It will also stimulate the immune system to respond to the influenza virus that was used in the vaccine, but other types of influenza viruses may still be contagious.
The prospective vaccine is scheduled to enter the first phase trials in Hong Kong next November, and it will be given to volunteers through the nose, and not through an injection of the body, as is the case with most vaccines.
08:22 PM
It is given through the nose, not as an injection
Hong Kong researchers have developed a vaccine, the first of its kind. It can protect against the emerging corona virus and influenza together, according to what Al-Hurra reported today, Saturday.
Yuen Kwok Young, head of the infectious diseases department in the Department of Microbiology at the University of Hong Kong, indicated that experiments showed that the vaccine works well in animals.
The vaccine uses a weakened influenza virus that only grows in the upper airway and cannot reproduce, and it has been genetically engineered to include the Corona virus protein as well.
The vaccine will trigger an immune response and the production of antibodies that will prevent the real virus from spreading in the body. It will also stimulate the immune system to respond to the influenza virus that was used in the vaccine, but other types of influenza viruses may still be contagious.
The prospective vaccine is scheduled to enter the first phase trials in Hong Kong next November, and it will be given to volunteers through the nose, and not through an injection of the body, as is the case with most vaccines.
These were the details of the news Researchers are developing a vaccine that treats “Corona” and influenza together for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
